| Title of Invention | TOPICAL FORMULATIONS |
|---|---|
| Abstract | Topical formulation comprising COX-II inhibitor either alone or in combination with an analgesic drug and pharmaceutically acceptable excipients in the form of transparent or opaque gel formulations for the treatment of painful inflammatory joint diseases like osteo arthritis (OA), rheumatoid arthritis, peri-arthritis, tennis elbow and frozen shoulder is disclosed herein. |
| Full Text | FORM 2 THE PATENTS ACT, 1970 (39 of 1970) PROVISIONAL SPECIFICATION [See section 10; RULE 13] "TOPICAL FORMULATIONS" (a) M/s LYKA LABS LIMITED. (b) 77, Nehru Road, Vile Parle (East) Mumbai - 400 099, Maharashtra, India (c) Indian Company incorporated under the Companies Act 1956 1 3 AUG 2004 The following specification particularly describes the nature of the invention: |
|---|
879-mum-2004-cancelled pages(13-08-2004).pdf
879-mum-2004-claims(granted)-(04-07-2007).doc
879-mum-2004-claims(granted)-(04-07-2007).pdf
879-mum-2004-correspondence(04-07-2007).pdf
879-mum-2004-correspondence(ipo)-(11-06-2007).pdf
879-mum-2004-form 1(12-08-2004).pdf
879-mum-2004-form 18(5-12-2006).pdf
879-mum-2004-form 2(granted)-(04-07-2007).doc
879-mum-2004-form 2(granted)-(04-07-2007).pdf
879-mum-2004-form 3(13-08-2004).pdf
879-mum-2004-form 5(12-08-2005).pdf
| Patent Number | 216338 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 879/MUM/2004 | ||||||||||||
| PG Journal Number | 13/2008 | ||||||||||||
| Publication Date | 28-Mar-2008 | ||||||||||||
| Grant Date | 12-Mar-2008 | ||||||||||||
| Date of Filing | 13-Aug-2004 | ||||||||||||
| Name of Patentee | M/S. LYKA LABORATORIES LIMITED | ||||||||||||
| Applicant Address | 77 NEHRU ROAD, VILE PARLE (EAST), MUMBAI 400 099 | ||||||||||||
Inventors:
|
|||||||||||||
| PCT International Classification Number | A61K 31/522, A61K 31/365 | ||||||||||||
| PCT International Application Number | N/A | ||||||||||||
| PCT International Filing date | |||||||||||||
PCT Conventions:
|
|||||||||||||